San Antonio Express-News

Diabetes drug is the latest weight-loss trend

- By Elena Bruess

“If someone is at a perfectly good weight, but still uncomforta­ble with their body, these drugs are not for them.” Carolina Solis-herrera, endocrinol­og y specialist at University Health

When it comes to weightloss trends, the word on everyone’s lips these days is Ozempic.

It’s that so-called miracle drug that everyone from Tiktok influencer­s to celebritie­s have announced taking to lose weight quickly.

The drug has been around since 2017 to treat diabetes. And since 2021, it’s also been prescribed to treat obesity under the name Wegovy. The active ingredient in both — called semaglutid­e — lowers blood sugar levels and regulates insulin, and also prompts stomachs to empty more slowly, leaving people with decreased appetite and a lingering feeling of fullness.

Studies have found the drug is effective for patients with diabetes, obesity and some cardiovasc­ular diseases.

But people without any of those conditions recently have been asking their doctors for prescripti­ons to lose weight.

Carolina Solis-herrera, an endocrinol­ogy specialist at University Health and the endocrinol­ogy medical director at UT Health San Antonio, said the drug is not meant for people who are already at, or near, a healthy weight. Few studies have examined the effect the drug has on such patients.

“Our recommenda­tion for people at a healthy weight is just keep up a healthy lifestyle, which involves regular exercise and plenty of vegetables, less processed foods,” Solisherre­ra said. “And for those who are obese or have diabetes, it’s more reasonable to reach out to a physician about lifestyle changes along with medication.”

“Our recommenda­tion for people at a healthy weight is just keep up a healthy lifestyle ... regular exercise and plenty of vegetables.” Carolina Solis-herrera, endocrinol­og y specialist at University Health

But people who are looking to shed pounds fast and decide to take injections of Ozempic or Wegovy, or the tablet form, called Rybelsus, should be aware that the drug only lasts as long as you take it. Just like blood pressure medication­s, when someone stops taking the drug, the benefits stop. In the case of Ozempic, the hunger will return and the weight could come back.

“If someone is at a perfectly good weight, but still uncomforta­ble with their body, these drugs are not for them,” Solisherre­ra said. “They may want to try counseling to better understand that.”

Some of these patients — the ones already at or close to a healthy weight — are paying a bundle for the drugs. Without diabetes or obesity — which the U.S. Food and Drug Administra­tion has approved the drugs for — the cost can range from $800 to $1,200 a month without insurance, and some insurers may not cover the prescripti­ons for people without those conditions.

Recently there had been a shortage of the drugs, but Solisherer­a said that’s not because of the new weight-loss trend. A piece of the Wegovy injection device — its spring — was in short supply, prompting patients to move over to Ozempic to continue taking the semaglutid­e. Because of that switchover, supplies of Ozempic had been scarce.

In the past couple of weeks, however, production of the drugs is nearly back to normal, and many patients have been able to receive their prescripti­ons of Ozempic or Wegovy.

With all this talk about weight loss and diabetes, Solisherre­ra said San Antonio residents should always speak with a health care profession­al about these matters.

“Then you can find out what works best for you,” she said.

 ?? Staff file photo ?? Ozempic has been in short supply in recent weeks, but production of the drug now is nearly back to normal.
Staff file photo Ozempic has been in short supply in recent weeks, but production of the drug now is nearly back to normal.

Newspapers in English

Newspapers from United States